Women who were vaccinated against covid-19 in the luteal phase of their menstrual cycle reported having a breakthrough ...

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up 14% to $68 and change in afternoon trading Friday, extending a ...

Cancer was a key focus, with programs targeting solid tumors, Lynch syndrome, melanoma, and non-small cell lung cancer.

Key Points Interested in Moderna, Inc.? Here are five stocks we like better. Moderna shares rose nearly 20% after Science Day, but the gain is partly attributed to a short squeeze, not fundamentals ...

Moderna Inc. Chief Executive Officer Stephane Bancel said he sees the pending launch of a planned flu vaccine as a chance to ...

Anthropic's Claude Science is a workbench that gives scientists one environment to do computational research, saving them ...

Claude Science launches as big tech companies increasingly eye expansion in the wider healthcare space.

The review draws the formal regulatory distinction: gene therapy involves the deliberate and permanent alteration of a patient's genome. mRNA vaccines do not ...

The companies selling AI tools are also predicting they'll upend the workforce, and the planning implications are significant ...

If 2020 required us to constantly wear physical masks to protect ourselves from our environment, the aftermath of October 7 ...

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...

Congress introduced legislation this month allowing seriously ill patients to access select treatments their physicians would ...